Company Search:
Advanced Search
Sponsored Links
Xbrane Biopharma Ab Company Snapshot
Xbrane Biopharma Ab operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Xbrane Biopharma Ab with three other companies in this sector in Sweden: Medivir AB (2018 sales of 23.86 million Swedish Kronor [US$2.50 million] of which 100% was Pharmaceutical), Sprint Bioscience AB (17.94 million Swedish Kronor [US$1.88 million] ), and Active Biotech AB (20.05 million Swedish Kronor [US$2.10 million] of which 80% was Rental revenues).

Sales Analysis. Xbrane Biopharma Ab reported sales of SEK 20.49 million (US$2.15 million) for the year ending December of 2018. This represents a decrease of 1.4% versus 2017, when the company's sales were SEK 20.77 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Xbrane Biopharma Ab
  Stock Performance Chart for Xbrane Biopharma Ab
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 34.80
(Figures in Swedish Kronor)
1 Week 5.8%   13 Weeks 11.5%  
4 Weeks 18.4%   52 Weeks -24.4%  
Xbrane Biopharma Ab Key Data:
  Ticker: XBRANE Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 20,485,000
(Year Ending Jan 2019).
Employees: 28
  Currency: Swedish Kronor Market Cap: 536,448,925
  Fiscal Yr Ends: December Shares Outstanding: 15,415,199
  Share Type: Aktie Closely Held Shares: N/A
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.